In addition, H2BC18 had a hypermethylated status in germ cell tumors (GCT), cervical squamous cell carcinoma and endometrial adenocarcinoma (CSEC), and uterine carcinosarcoma (UCS) (Figure 12C). This evidence concerns the gene H2BC18 and testicular germ cell tumor.